Glimepiride, Metformin SR (Sustained Release), and Voglibose''"'"''''

Glimepiride, Metformin SR (Sustained Release), and Voglibose SEIZMET TRIO are medications commonly used in the management of diabetes mellitus. They belong to different classes of antidiabetic drugs and can be prescribed alone or in combination to help control blood sugar levels. 
Glimepiride is a sulfonylurea, which is a class of oral antidiabetic drugs.
It stimulates the release of insulin from the pancreas, thereby increasing insulin levels in the blood. This helps lower blood sugar levels.
Glimepiride is used to treat type 2 diabetes.
Metformin is a biguanide, another class of oral antidiabetic drugs.
Metformin primarily works by reducing the production of glucose by the liver and improving insulin sensitivity in the body's tissues, leading to better glucose utilization.
Metformin is commonly used to treat type 2 diabetes. The sustained-release (SR) formulation provides a gradual release of the medication over time.
Voglibose is an alpha-glucosidase inhibitor.
It works by inhibiting the action of alpha-glucosidase enzymes in the intestine. This slows down the digestion and absorption of carbohydrates, leading to a gradual increase in blood glucose levels after meals.
Voglibose is used in the management of postprandial (after-meal) hyperglycemia in individuals with type 2 diabetes.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/seizmet-trio-0-2-133445